{
    "organizations": [],
    "uuid": "0556ae11ee5dff829b36c5dbe35e1fb0173923ef",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-crescita-therapeutics-reports-qtrl/brief-crescita-therapeutics-reports-qtrly-net-loss-from-continuing-operations-per-share-0-03-idUSASC0A0XZ",
    "ord_in_thread": 0,
    "title": "Crescita Therapeutics™ Reports Qtrly Net Loss From Continuing Operations Per Share $0.03",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 9, 2018 / 11:46 AM / in 12 minutes BRIEF-Crescita Therapeutics™ Reports Qtrly Net Loss From Continuing Operations Per Share $0.03 Reuters Staff\nMay 9 (Reuters) - Crescita Therapeutics Inc:\n* CRESCITA THERAPEUTICS™ REPORTS 2018 FIRST QUARTER RESULTS\n* CRESCITA THERAPEUTICS INC QTRLY NET LOSS FROM CONTINUING OPERATIONS PER SHARE $0.03 Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)",
    "published": "2018-05-09T19:46:00.000+03:00",
    "crawled": "2018-05-09T15:03:20.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "minute",
        "report",
        "qtrly",
        "net",
        "loss",
        "continuing",
        "operation",
        "per",
        "share",
        "reuters",
        "staff",
        "may",
        "reuters",
        "crescita",
        "therapeutic",
        "inc",
        "crescita",
        "report",
        "first",
        "quarter",
        "result",
        "crescita",
        "therapeutic",
        "inc",
        "qtrly",
        "net",
        "loss",
        "continuing",
        "operation",
        "per",
        "share",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}